Oruka Therapeutics (ORKA) Net Income towards Common Stockholders (QoQ) (2010 - 2024)
Oruka Therapeutics (ORKA) Net Income towards Common Stockholders (QoQ) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Oruka Therapeutics | 949.58 Mn | 118.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -157.93% |
| Mar 31, 2024 | -528.61% |
| Dec 31, 2023 | 36.79% |
| Sep 30, 2023 | -15.67% |
| Jun 30, 2023 | -10.59% |
| Mar 31, 2023 | -17.46% |
| Dec 31, 2022 | 50.98% |
| Sep 30, 2022 | 34.46% |
| Jun 30, 2022 | -10.66% |
| Mar 31, 2022 | 41.83% |
| Dec 31, 2021 | -20.46% |
| Sep 30, 2021 | 2.52% |
| Jun 30, 2021 | -17.70% |
| Mar 31, 2021 | 21.68% |
| Dec 31, 2020 | -163.39% |
| Sep 30, 2020 | -52.92% |
| Jun 30, 2020 | 1.36% |
| Mar 31, 2020 | -7.67% |
| Dec 31, 2019 | -6.06% |
| Sep 30, 2019 | 19.50% |